Stat : Canadian Drug Price Board Member Resigns Over Government Failure Вђto Support Real Changeвђ™ - Mr Validity [ iOS DELUXE ]
: He criticized then-Health Minister Jean-Yves Duclos for intervening on behalf of the pharmaceutical industry by asking the board to suspend consultations on new pricing guidelines.
: Herder noted that the federal government delayed the introduction of new pricing regulations four separate times, accepting industry claims that more time was needed. : He criticized then-Health Minister Jean-Yves Duclos for
: Herder stated the government’s actions were "largely indistinguishable in form and substance from industry talking points," leaving the regulator in an "endless tunnel with no light". Context and Fallout Context and Fallout In February 2023, , a
In February 2023, , a member of Canada’s Patented Medicine Prices Review Board (PMPRB) , resigned in a blistering letter to the federal government. Herder , a health law expert at Dalhousie University , accused the Liberal government of failing to support "real change" and undermining the regulator's independence to favor the pharmaceutical industry. Key Reasons for Resignation Context and Fallout In February 2023